戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 iated disease; 14 [37%] of 38 with community-acquired disease).
2 patients (five with congenital and five with acquired disease).
3 ion SEPs (two with congenital and three with acquired disease).
4 n their function underlie both inherited and acquired disease.
5 pendent phosphorylation in human genetic and acquired disease.
6  patterns, including patients with community-acquired disease.
7 atients, including 4 patients with community-acquired disease.
8 ngly recognized as a model for inherited and acquired disease.
9 after myocardial infarction (MI), a model of acquired disease.
10  than those individuals with non-transfusion-acquired disease.
11  therapeutic strategy for many inherited and acquired diseases.
12 ic diseases, tumors, vascular anomalies, and acquired diseases.
13 rapies and research models for inherited and acquired diseases.
14  the genome and may manifest as inherited or acquired diseases.
15 inical trials to treat genetic disorders and acquired diseases.
16 n the clinical treatment of many genetic and acquired diseases.
17  target for gene therapies for inherited and acquired diseases.
18 n the management of several gene defects and acquired diseases.
19  therapeutic strategy for many inherited and acquired diseases.
20 is vector for the treatment of inherited and acquired diseases.
21 oft tissue calcification in both genetic and acquired diseases.
22 fering innovative treatments for genetic and acquired diseases.
23 herapy of hyperammonemia in both genetic and acquired diseases.
24 gical calcium signaling, both in genetic and acquired diseases.
25 the relevance of these findings in naturally acquired disease, a composite influenza A signature buil
26  channel that is important in hereditary and acquired diseases affecting urine-concentrating ability.
27  allow us to address the epigenetic state of acquired disease and whether original states, regenerati
28 lly treating a large array of hereditary and acquired diseases, and stands as the paradigm for stem c
29                   A variety of heritable and acquired diseases are linked to mitochondrial dysfunctio
30 his regulation is corrupted in hereditary or acquired diseases associated with elevated sulfide.
31 imple sequence polymorphisms but no apparent acquired disease-associated mutations.
32 atients, of whom 96% likely had nosocomially acquired disease at 11 hospitals.
33 utionize the treatment of both inherited and acquired diseases, by transferring nucleic acids to corr
34 t of a growing, clinically relevant hospital-acquired disease, C. difficile infection.
35 tellation that develops secondary to various acquired diseases, especially intrathoracic neoplasm.
36 field of gene therapy for both inherited and acquired diseases, especially with regard to respiratory
37                 The lethality rate of orally-acquired disease has declined over the years.
38          An increasing number of genetic and acquired diseases has been associated with intracellular
39 at, when defective, can cause congenital and acquired disease in Homo sapiens.
40 ificantly associated with invasive community-acquired disease in humans.
41 t of congenital toxoplasmosis or postnatally acquired disease in immunocompromised patients.
42 nitially knew little about the diseases, but acquired disease information and increased knowledge of
43 s for phenotypic expression of heritable and acquired diseases involving abnormality in the ABCC6 gen
44                           Constitutional and acquired disease is poorly delineated, as lesions in som
45 viduals or animals suffering from genetic or acquired diseases, it is important to identify which cli
46  finding in patients with both inherited and acquired diseases of heart muscle.
47 ent neurological disability in inherited and acquired diseases of myelin.
48                                Heritable and acquired diseases of podocytes can result in focal and s
49                               Congenital and acquired diseases of the biliary tree, or cholangiopathi
50                               Congenital and acquired diseases of the heart valves and great arteries
51 ly curative treatment for both inherited and acquired diseases of the hematopoietic compartment; howe
52 ay be differentially affected in genetic and acquired diseases of the human brain.
53 athies, a group of genetic developmental and acquired diseases of the liver.
54 ses in humans, including both hereditary and acquired disease processes.
55 tive differences in gene-for-gene, basal and acquired disease resistance and other aspects of plant i
56                                Such chronic, acquired diseases result when normal physiologic control
57 loped countries in the setting of genetic or acquired disease states.
58  is directly linked with both congenital and acquired disease states.
59 nome evolution and can underlie inherited or acquired diseases such as cancer.
60 ients with congenital disease and those with acquired disease, suggesting that factors additional to
61 BM) of the kidney is impaired in genetic and acquired diseases that affect type IV collagen.
62               Most patients had nosocomially acquired disease, were infected with HIV, and unless pro
63  common health-care-associated and community-acquired disease with few antibiotic treatment options.
64  most important causative agents of hospital-acquired diseases worldwide.